Cargando…

Long-Term Health Effects of Curative Therapies on Heart, Lungs, and Kidneys for Individuals with Sickle Cell Disease Compared to Those with Hematologic Malignancies

The goal of curing children and adults with sickle cell disease (SCD) is to maximize benefits and minimize intermediate and long-term adverse outcomes so that individuals can live an average life span with a high quality of life. While greater than 2000 individuals with SCD have been treated with cu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fitzhugh, Courtney D., Volanakis, Emmanuel J., Idassi, Ombeni, Duberman, Josh A., DeBaun, Michael R., Friedman, Debra L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181610/ https://www.ncbi.nlm.nih.gov/pubmed/35683502 http://dx.doi.org/10.3390/jcm11113118

Ejemplares similares

Clonal Hematopoiesis and the Risk of Hematologic Malignancies after Curative Therapies for Sickle Cell Disease
por: Gondek, Lukasz P., et al.
Publicado: (2022)

Adapting medical guidelines to be patient-centered using a patient-driven process for individuals with sickle cell disease and their caregivers
por: Cronin, Robert Michael, et al.
Publicado: (2018)

Altered VWF:ADAMTS13 homeostasis is a target for therapeutic intervention in sickle cell disease
por: Chaturvedi, Shruti, et al.
Publicado: (2022)

Sexual violence as a precipitator of chronic pain in young adults with sickle cell disease
por: Chopra, Maya, et al.
Publicado: (2022)

Vaso-Occlusive Pain and Menstruation in Sickle Cell Disease: A Focus Group Analysis
por: Day, Melissa, et al.
Publicado: (2020)

Improved Guideline Adherence With Integrated Sickle Cell Disease and Asthma Care
por: McClain, Brandi L., et al.
Publicado: (2016)

2484: Establishment of the Tennessee-sickle cell disease network as a mechanism for engaging a rare disease population in patient centered outcomes research
por: Mayo-Gamble, Tilicia, et al.
Publicado: (2018)

Risk factors for hospitalizations and readmissions among individuals with sickle cell disease: results of a U.S. survey study
por: Cronin, Robert M., et al.
Publicado: (2019)

Annual decline in lung function in adults with sickle cell disease is similar to that observed in adults with cystic fibrosis
por: Hodges, Brock, et al.
Publicado: (2022)

Sickle Cell Disease Clinical Trials and Phenotypes
por: Ezekekwu, Chinedu A, et al.
Publicado: (2018)

A feasibility randomized controlled trial of an mHealth app vs booklets for patient-facing guidelines in adults with SCD
por: Cronin, Robert M., et al.
Publicado: (2023)

The Role of Fibrocytes in Sickle Cell Lung Disease
por: Field, Joshua J., et al.
Publicado: (2012)

Offensive Feet
por: DeBaun, Edwin
Publicado: (1887)

Patient-Centered eHealth Interventions for Children, Adolescents, and Adults With Sickle Cell Disease: Systematic Review
por: Badawy, Sherif M, et al.
Publicado: (2018)

The use of FDA-approved medications for preventing vaso-occlusive events in sickle cell disease
por: Cronin, Robert M., et al.
Publicado: (2023)

Choice of Donor Source and Conditioning Regimen for Hematopoietic Stem Cell Transplantation in Sickle Cell Disease
por: Limerick, Emily, et al.
Publicado: (2019)

Initiating adjunct low-dose hydroxyurea therapy for stroke prevention in children with SCA during the COVID-19 pandemic
por: DeBaun, Michael R.
Publicado: (2020)

Risk factors in underweight older children with sickle cell anemia: a comparison of low- to high-income countries
por: Klein, Lauren Jane, et al.
Publicado: (2023)

Underweight children older than 5 years with sickle cell anemia are at risk for early mortality in a low-resource setting
por: Klein, Lauren J., et al.
Publicado: (2022)

Identifying Elevated Risk for Future Pain Crises in Sickle-Cell Disease Using Photoplethysmogram Patterns Measured During Sleep: A Machine Learning Approach
por: Ji, Yunhua, et al.
Publicado: (2021)

Genome-Wide Meta-Analysis of Systolic Blood Pressure in Children with Sickle Cell Disease
por: Bhatnagar, Pallav, et al.
Publicado: (2013)

Incidence and predictors of priapism events in sickle cell anemia: a diary-based analysis
por: Idris, Ibrahim M., et al.
Publicado: (2022)

Effect of Blood Transfusion on Cerebral Hemodynamics and Vascular Topology Described by Computational Fluid Dynamics in Sickle Cell Disease Patients
por: Sawyer, Russell P., et al.
Publicado: (2022)

Development of curative therapies for sickle cell disease
por: Tanhehco, Yvette C., et al.
Publicado: (2022)

How I curate: applying American Society of Hematology-Clinical Genome Resource Myeloid Malignancy Variant Curation Expert Panel rules for RUNX1 variant curation for germline predisposition to myeloid malignancies
por: Wu, David, et al.
Publicado: (2020)

Stem Cell Yield after Bone Marrow Concentration
por: Dragoo, Jason L., et al.
Publicado: (2017)

Creating an automated contemporaneous cohort in sickle cell anemia to predict survival after disease-modifying therapy
por: Cronin, Robert M., et al.
Publicado: (2022)

COVID‐19 pneumonia in a pediatric sickle cell patient requiring red blood cell exchange
por: Walker, Shannon C., et al.
Publicado: (2021)

Feasibility trial for the management of severe acute malnutrition in older children with sickle cell anemia in Nigeria
por: Abdullahi, Shehu U., et al.
Publicado: (2023)

Epidemiology of Maternal Nutritional Status and Risk of Adverse Birth Outcomes in Undernourished Mothers with Sickle Cell Disease: A Systematic Review and Meta-Analysis Protocol
por: Klein, Lauren J., et al.
Publicado: (2023)

Silent infarction in sickle cell disease is associated with brain volume loss in excess of infarct volume
por: Jones, R. Sky, et al.
Publicado: (2023)

Translating research to usual care of children with sickle cell disease in Northern Nigeria: lessons learned from the SPRING Trial Team
por: Bello-Manga, Halima, et al.
Publicado: (2022)

Investigational curative gene therapy approaches to sickle cell disease
por: Williams, David A., et al.
Publicado: (2021)

Development of a conceptual model for evaluating new non-curative and curative therapies for sickle cell disease
por: Johnson, Kate M., et al.
Publicado: (2022)

Outcomes before and after providing interdisciplinary hematology and pulmonary care for children with sickle cell disease
por: Zeno, Rachel N., et al.
Publicado: (2022)

Accuracy of diagnosis and individualization of treatment: the way of treating hematologic malignancies
por: Liu, Dai-Hong
Publicado: (2020)

Estimated Life Expectancy and Income of Patients With Sickle Cell Disease Compared With Those Without Sickle Cell Disease
por: Lubeck, Deborah, et al.
Publicado: (2019)

Hematological parameters in Ghanaian sickle cell disease patients
por: Antwi-Boasiako, Charles, et al.
Publicado: (2018)

Hematologic malignancies and Li–Fraumeni syndrome
por: Swaminathan, Mahesh, et al.
Publicado: (2019)

Academic Medicine’s Journey Toward Racial Equity Must Be Grounded in History: Recommendations for Becoming an Antiracist Academic Medical Center
por: Wilkins, Consuelo H., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_eqlbgpd4c2jn0jlr1iat0dl6in